# EZETIMIBE AND SIMVASTATIN
> **ANDA208699** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2019-06-27
## Drug
- **FDA Application Number:** ANDA208699
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EZETIMIBE AND SIMVASTATIN
- **Generic name:** EZETIMIBE AND SIMVASTATIN
- **Active ingredients:** EZETIMIBE; SIMVASTATIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2019-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208699)
---
*MORVS · CC0 1.0*